Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Moderna a Buy?

TheMotleyFool

0 0

Is Moderna a Buy?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Biotech stocks have become more in demand than usual because of the coronavirus outbreak. With the need for a vaccine growing by the day, this unfortunate situation has given many vaccine developers the chance to make headlines. Moderna (NASDAQ: MRNA) is one of these companies. A $7.7 billion drug developer that specializes in messenger RNA (mRNA) vaccine treatments, the company caught quite a bit of attention back in late 2018 for being the biggest biotech IPO in history.

While there's plenty of interest surrounding this stock right now, what are its long-term prospects? Let's dive a bit deeper and see whether Moderna is truly worth a spot in your portfolio.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Teilen